INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

10497	Companies
221364	Keywords
150537	Articles
117052	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 02/10/2025 at 22:00, 1 year 3 months ago

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update
Inventiva reports preliminary 2024 fiscal year financial results and business update, with €9.2 million revenues and €96.6 million cash as of December 31, 2024. Focused on lanifibranor development

Revenues Financial Results 2024 Fiscal Year Inventiva Lanifibranor
BRIEF

published on 01/24/2025 at 22:05, 1 year 4 months ago

Half-yearly report on Inventiva's liquidity contract with Kepler Cheuvreux

Liquidity Contract Kepler Cheuvreux Biopharmaceutical Stock Market Transactions Inventiva
PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 4 months ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announces half-year liquidity contract review with Kepler Cheuvreux. Cash and shares available in the liquidity account disclosed. Company focuses on developing oral small molecule therapies for MASH and unmet medical needs

Liquidity Contract Kepler Cheuvreux Clinical-Stage Biopharmaceutical Inventiva MASH
BRIEF

published on 01/22/2025 at 22:05, 1 year 4 months ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year 4 months ago

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D

Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
BRIEF

published on 12/17/2024 at 22:05, 1 year 5 months ago

Inventiva to present at the JP Morgan Healthcare Conference

Investors Inventiva NASH Lanifibranor JP Morgan Healthcare
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 5 months ago

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings

Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction
BRIEF

published on 12/12/2024 at 22:05, 1 year 5 months ago

Inventiva Announces Shareholders’ Meeting Vote Results

Voting Results Shareholders' Meeting Biopharmaceutical Resolutions Inventiva
PRESS RELEASE

published on 12/12/2024 at 22:00, 1 year 5 months ago

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024
Inventiva announces voting results of Combined Shareholders' General Meeting on December 11, 2024. All resolutions were adopted except the 59th resolution

Voting Results Shareholders' Meeting Clinical-Stage Biopharmaceutical Inventiva NASH
BRIEF

published on 11/21/2024 at 22:05, 1 year 6 months ago

Inventiva's Financial Overview for Q3 2024

Financial Results Cash Position Equity Raise Royalty Certificates R&D Expenses

Accesswire

Published on 06/03/2026 at 10:30, 2 hours 21 minutes ago

Silver Range Partner Excalibur Metals Intersects a Broad Precious Metals Zone, Open at Depth at the Bellehelen Property
Published on 06/03/2026 at 10:00, 2 hours 51 minutes ago

Eagle Plains and Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, SK
Published on 06/03/2026 at 09:05, 3 hours 46 minutes ago

2026 Letter to Nano One Stakeholders
Published on 06/03/2026 at 09:01, 3 hours 50 minutes ago

Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 7 hours 53 minutes ago

Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026

View all ACCESSWIRE

EQS Group

Published on 06/03/2026 at 12:45, 6 minutes ago

Hong Kong forges new opportunities with Kazakhstan and Central Asia
Published on 06/03/2026 at 12:40, 11 minutes ago

Infosys and LTA Launch AI-Driven Match and Fan Experiences at the HSBC Championships, and Beyond
Published on 06/03/2026 at 12:18, 32 minutes ago

RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 3 June 2026
Published on 06/03/2026 at 12:12, 39 minutes ago

Worthington Steel Completes Acquisition of Kloeckner & Co and Announces Intention to Launch Delisting Tender Offer
Published on 06/03/2026 at 12:10, 41 minutes ago

EQS-WpÜG: Tender Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH

Les Echos

Published on 06/03/2026 at 12:41, 10 minutes ago

Disclosure of Share Capital and Voting Rights as of Mai 31, 2026
Published on 06/03/2026 at 11:29, 1 hour 22 minutes ago

2026.06.03 Notice to holders of the Convertible Bond ISIN FR0013521085
Published on 06/03/2026 at 08:45, 4 hours 6 minutes ago

Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 18 hours 48 minutes ago

Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 19 hours 9 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 May 2026

View all LES ECHOS COMFI WIRE